本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPYRE THERAPEUTICS INC

80.45
-5.4500-6.34%
盘后:80.450.00000.00%19:30 EDT
成交量:144.11万
成交额:1.19亿
市值:74.25亿
市盈率:-40.03
高:85.32
开:85.12
低:80.45
收:85.90
52周最高:110.18
52周最低:18.71
股本:9,229.14万
流通股本:8,161.70万
量比:0.64
换手率:1.77%
股息:- -
股息率:- -
每股收益(TTM):-2.0100
每股收益(LYR):-1.9755
净资产收益率:-22.98%
总资产收益率:-19.81%
市净率:7.78
市盈率(LYR):-40.72

数据加载中...

2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/26

SEC问询函

Form CORRESP - Correspondence
2024/04/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/29

SEC问询函

Form CORRESP - Correspondence
2024/03/27

SEC问询函

Form CORRESP - Correspondence
2024/03/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

SEC问询函

Form CORRESP - Correspondence
2024/03/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/02

SEC问询函

Form CORRESP - Correspondence
2024/03/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/01

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]